VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 2 filers reported holding VECTIVBIO HLDG AG in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,945,093 | +5.0% | 2,782,756 | -47.1% | 14.24% | +20.0% |
| Q1 2023 | $44,724,170 | -6.0% | 5,255,484 | -4.3% | 11.87% | -6.3% |
| Q4 2022 | $47,595,916 | +92.6% | 5,492,893 | +33.3% | 12.68% | +90.7% |
| Q3 2022 | $24,717,000 | +21.0% | 4,119,572 | +8.9% | 6.65% | -14.8% |
| Q2 2022 | $20,424,000 | +40.6% | 3,782,199 | +22.6% | 7.80% | +26.3% |
| Q1 2022 | $14,527,000 | +10.6% | 3,084,310 | +15.3% | 6.18% | +41.7% |
| Q4 2021 | $13,136,000 | -34.4% | 2,675,408 | +3.2% | 4.36% | -25.4% |
| Q3 2021 | $20,028,000 | -33.6% | 2,592,602 | +0.3% | 5.85% | -16.7% |
| Q2 2021 | $30,152,000 | – | 2,585,986 | – | 7.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,782,199 | $20,424,000 | 7.80% |
| CAXTON CORP | 194,577 | $1,051,000 | 1.41% |
| Cormorant Asset Management, LP | 2,840,389 | $15,338,000 | 1.16% |
| Novo Holdings A/S | 3,339,484 | $18,033,000 | 0.89% |
| Orbimed Advisors | 6,473,561 | $34,957,000 | 0.63% |
| Bpifrance SA | 2,806,217 | $15,154,000 | 0.57% |
| Eventide Asset Management | 2,339,044 | $12,631,000 | 0.27% |
| Tekla Capital Management LLC | 756,502 | $4,085,000 | 0.16% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 865,229 | $4,672,000 | 0.08% |
| Canaan Partners XI LLC | 37,051 | $200,000 | 0.07% |